TG Therapeutics Inc - רווח עתידי TGTX

סמל תאגידי ולוגו של TG Therapeutics, Inc. (TGTX)

The embedded profit level demonstrates the dynamics of expected earnings, where the 0.42 mark characterizes this parameter. TG Therapeutics, Inc. (TGTX) is expanding its presence in sclerosis therapy due to the efficacy of its flagship product. Production is based on outsourcing, which makes supplies dependent on external plants. Meanwhile, tech giants with massive advertising resources pose a serious threat.

TGTX: רווח צפוי TG Therapeutics, Inc. 30.07.2023 - 18.11.2026

פילוחי מדדים ואנליטיקה של חברת TG Pharma (TGTX)

- מחיר ותחזית קונצנזוס למחירים:
ניתוח פונדמנטלי של החברה:TG Therapeutics Corp, TGTX
מוצר עיקרי של TG Therapeutics Corp

The successful market launch of the drug confirms the competencies of TG Therapeutics, Inc. (TGTX) management, although a high dependency on the CEO increases the importance of analyzing the projected financial return. This indicator is calculated as the sum of expected net income for future periods, allowing the investor to compare current capitalization with potential profitability and determine the fairness of the asset's market valuation.